Literature DB >> 24159006

Practice tips and tools for the successful use of U-500 regular human insulin: the diabetes educator is key.

Elaine K Cochran1, Virginia Valentine2, Karen H Samaan3, Ilene B Corey4, Jeffrey A Jackson4.   

Abstract

This review provides information to equip diabetes educators to instruct and guide patients in using U-500 human regular insulin (U-500R). The article includes an overview of U-500R pharmacology and clinical data, strategies for outpatient and inpatient use, and tools for patient education. U-500R is useful for treating patients with any type of diabetes who require high doses of insulin. U-500R alleviates the volume-related problems associated with high doses of U-100 insulin, making treatment with high doses of insulin more feasible (because of the need for fewer injections for patients) as well as more cost-efficient and potentially more effective. These tools can help diabetes educators feel more comfortable and confident as they advise and educate patients who receive high-dose U-500R as part of their overall diabetes care plan. The diabetes educator plays a vital role in helping patients use U-500R safely and successfully.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24159006     DOI: 10.1177/0145721713508822

Source DB:  PubMed          Journal:  Diabetes Educ        ISSN: 0145-7217            Impact factor:   2.140


  8 in total

1.  Treatment Patterns, Adherence, and Persistence Associated With Human Regular U-500 Insulin: A Real-World Evidence Study.

Authors:  Jieling Chen; Christi Y Kao; Xuanyao He; Ludi Fan; Jeffrey A Jackson; Rattan Juneja
Journal:  Diabetes Spectr       Date:  2020-08

2.  Clinical considerations for insulin pharmacotherapy in ambulatory care, part two: review of primary literature and an evidence-based approach for treatment.

Authors:  Maria Miller Thurston; John A Galdo; Catherine A Bourg
Journal:  Clin Diabetes       Date:  2015-01

3.  Initiation of human regular U-500 insulin use is associated with improved glycemic control: a real-world US cohort study.

Authors:  Elizabeth L Eby; Bradley H Curtis; Steven C Gelwicks; Robert C Hood; Iskandar Idris; Anne L Peters; Richard M Bergenstal; Jeffrey A Jackson
Journal:  BMJ Open Diabetes Res Care       Date:  2015-04-30

4.  Translating U-500R Randomized Clinical Trial Evidence to the Practice Setting: A Diabetes Educator/Expert Prescriber Team Approach.

Authors:  Paula M Bergen; Davida F Kruger; April D Taylor; Wael E Eid; Arti Bhan; Jeffrey A Jackson
Journal:  Diabetes Educ       Date:  2017-04-21       Impact factor: 2.140

5.  Mild Caloric Restriction Decreases Insulin Requirements in Patients With Type 2 Diabetes and Severe Insulin Resistance.

Authors:  Cristina Adelia Meehan; Elaine Cochran; Megan Mattingly; Phillip Gorden; Rebecca J Brown
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

6.  Advances in Insulin Therapy: A Review of New Insulin Glargine 300 Units/mL in the Management of Diabetes.

Authors:  John R White
Journal:  Clin Diabetes       Date:  2016-04

7.  Clinical Challenges With Concentrated Insulins: Setting the Record Straight.

Authors:  Cynthia S A Brusko; April D Taylor; Jeffrey A Jackson; Mathijs C Bunck
Journal:  Diabetes Spectr       Date:  2017-11

8.  Human regular U-500 insulin via continuous subcutaneous insulin infusion versus multiple daily injections in adults with type 2 diabetes: The VIVID study.

Authors:  George Grunberger; Anuj Bhargava; Trang Ly; Howard Zisser; Liza L Ilag; James Malone; Ludi Fan; Shuyu Zhang; Jennal Johnson
Journal:  Diabetes Obes Metab       Date:  2020-01-26       Impact factor: 6.577

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.